Malignancy-associated hypercalcemia is a condition where cancer causes abnormally high calcium levels in the blood. It happens when certain tumors release substances that raise calcium, or when cancer spreads to bones and releases calcium into the bloodstream. This is one of the most common metabolic complications in people with cancer.
Your bones store most of your body's calcium. Normally, your body carefully controls how much calcium stays in your blood. When cancer disrupts this balance, calcium levels can climb too high. Some tumors produce proteins that act like parathyroid hormone, which tells your body to release more calcium from bones. Other cancers directly destroy bone tissue, releasing stored calcium.
This condition most often occurs with lung cancer, breast cancer, kidney cancer, and blood cancers like multiple myeloma. It can develop at any stage of cancer but often signals advanced disease. High calcium levels can affect your kidneys, heart, digestive system, and brain if left untreated.